Boston Scientific Failed To License Discovery IVUS Catheter To HP - FTC
This article was originally published in The Gray Sheet
Executive Summary
The ability of Boston Scientific's Discovery intravascular ultrasound catheter to function as a diagnostic and therapeutic tool excluded the product from the firm's consent agreement with the Federal Trade Commission, the firm claims in response to a lawsuit filed Oct. 31 in a Boston federal court.
You may also be interested in...
Boston Scientific May Appeal Fine For 1995 FTC Consent Decree Violation
Boston Scientific is weighing whether to appeal a $7 mil. civil penalty for failing to supply its Discovery intravascular ultrasound catheters and a patent license to Hewlett-Packard under a 1995 FTC consent decree
Boston Scientific May Appeal Fine For 1995 FTC Consent Decree Violation
Boston Scientific is weighing whether to appeal a $7 mil. civil penalty for failing to supply its Discovery intravascular ultrasound catheters and a patent license to Hewlett-Packard under a 1995 FTC consent decree
Boston Scientific Says Potential FTC Penalties Will Have No Material Impact
Boston Scientific's potential liability for failure to supply Discovery intravascular ultrasound catheters to Hewlett-Packard and provide an IVUS patent license under a 1995 consent order would not result in a "material" financial impact, Boston Scientific says.